Why Resmed, Coles, Afterpay and one other have made early share price gains

Share price gains of more than 2% have seen these four ASX large caps reverse the falls of yesterday. Here’s why.
The post Why Resmed, Coles, Afterpay and one other have made early share price gains appeared first on Motley Fool Australia. –

lots of hands all making thumbs up gesture

The share prices of a number of ASX companies have reversed yesterdays losses and made rapid share price gains in morning trade today. Here are four of the leading large caps and some reasons why they have made such a healthy turnaround. 

Afterpay Ltd (ASX: APT)

Afterpay has published very strong first quarter growth figures in its Q1 update today. The company reported a 115% increase in underlying sales to a record of $4.1 billion in Q1. In summary, the US recorded a 229% increase in sales with a 346% step change in UK and a 63% lift in Australia. Moreover, the company’s active user base has grown to 11 million globally.

The company said like-for-like sales growth was driven by Millennials, which accounted for 45 per cent of the increase. Afterpay also noted that defaults were “below historical rates” in all regions. The Afterpay share price has surged 5.26% up at the time of writing.

Resmed CDI (ASX: RMD)

Resmed has also seen its share price reverse yesterday’s trend, rising by 4.3% at the time of writing. Morgan Stanley raised its Resmed share price target this week. Moving it from $25.40 to $25.90 due to its belief in strong growth despite the pandemic. The company is due to deliver its Q1 results tomorrow which are expected to continue the performance of its FY20 annual report

Fisher & Paykel Healthcare Corp Ltd (ASX: FPH)

Fisher & Paykel has seen its share price jump up by 4.5% in early trading underlining its status as a ‘go to’ healthcare share for many investors. The company booked a record FY20 profit after sales of respiratory and home care products helped lift the company’s full-year profit 10 per cent. At this time, the company stated that an estimated three million patients were treated with its Optiflow respiratory products during the year.

Coles Group Ltd (ASX: COL)

Supermarket large cap Coles has reported Q1 results above expectations. Same-store supermarket sales rose 9.7 per cent in the September quarter. This was due to a popular Little House collectibles promotion, and strong online and in-store Victorian demand. This is the company’s second-highest quarterly comparable stores sales growth since it was taken over by Wesfarmers Ltd (ASX: WES).

As many still live with some restrictions, there were strong sales of baking mixes, herbs and spices, and cleaning goods.

Man who said buy Kogan shares at $3.63 says buy these 3 ASX stocks now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

Find out the names of our 3 Post COVID Stocks – For FREE!

*Returns as of 6/8/2020

More reading

Daryl Mather has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of AFTERPAY T FPO. The Motley Fool Australia owns shares of COLESGROUP DEF SET. The Motley Fool Australia has recommended ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post Why Resmed, Coles, Afterpay and one other have made early share price gains appeared first on Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!